G. CARRAZ, Darbon; S. Lebreton; H. Beriel, [Pharmacodynamic properties of 2,2-dipropylacetic acid and its derivatives. 4th report: 2,2-dipropylacetamide]., in Therapie, vol.19, pp.468-76, PMID 14138084.
GM. Pacifici, M. Franchi; C. Bencini; A. Rane, Valpromide inhibits human epoxide hydrolase., in Br J Clin Pharmacol, vol.22, n.3, Set 1986, pp.269-74, PMID 3094569.
F. Pisani, A. Fazio; G. Oteri; E. Spina; E. Perucca; L. Bertilsson, Effect of valpromide on the pharmacokinetics of carbamazepine-10, 11-epoxide., in Br J Clin Pharmacol, vol.25, n.5, Mag 1988, pp.611-3, PMID 3136790.
BM. Kerr, AE. Rettie; AC. Eddy; P. Loiseau; M. Guyot; AJ. Wilensky; RH. Levy, Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: in vitro/in vivo correlation., in Clin Pharmacol Ther, vol.46, n.1, Lug 1989, pp.82-93, PMID 2501059.
F. Pisani, AA. D'Agostino; A. Fazio; G. Oteri; G. Primerano; R. Di Perri, Increased dipropylacetic acid bioavailability from dipropylacetamide by food., in Epilepsia, vol.23, n.2, aprile 1982, pp.115-21, PMID 6804222.
M. Bialer, A. Rubinstein; I. Raz; O. Abramsky, Pharmacokinetics of valpromide after oral administration of a solution and a tablet to healthy volunteers., in Eur J Clin Pharmacol, vol.27, n.4, 1984, pp.501-3, PMID 6440792.
G. Benjelloun, K. Blandin; P. Fossati, [Valpromide, Valproic acid and removal of small intestine in the treatment of a chronic depression: a case report]., in Encephale, vol.30, n.4, pp.400-3, PMID 15538315.
F. Pisani, R. Di Perri, Some clinical pharmacological aspects of n-dipropylacetamide., in Ital J Neurol Sci, vol.1, n.4, Ott 1980, pp.245-9, PMID 6802780.
PA. Lambert, G. Carraz; S. Borselli; M. Bouchardy, [Dipropylacetamide in the treatment of manic-depressive psychosis]., in Encephale, vol.1, n.1, 1975, pp.25-31, PMID 1132367.
E. Vencovský, E. Peterová; J. Kabes, [Preventive effect of dipropylacetamide in bipolar manic-depressive psychoses]., in Psychiatr Neurol Med Psychol (Leipz), vol.39, n.6, Giu 1987, pp.362-4, PMID 3116572.
AC. Altamura, R. Basile; M. Mauri; CL. Cazzullo, [Valpromide (Depamide) in the treatment of acute psychotic states. Open clinical study]., in Acta Psychiatr Belg, vol.86, n.3, pp.297-304, PMID 2875606.
P. Bourrier, N. Varache; P. Alquier; D. Rabier; P. Kamoun; G. Lorre; G. Alhayek, [Cerebral edema with hyperammonemia in valpromide poisoning. Manifestation in an adult, of a partial deficit in type I carbamylphosphate synthetase]., in Presse Med, vol.17, n.39, novembre 1988, pp.2063-6, PMID 2974563.
C. Payen, P. Frantz; O. Martin; F. Parant; M. Moulsma; C. Pulce; J. Descotes, Delayed toxicity following acute ingestion of valpromide., in Hum Exp Toxicol, vol.23, n.3, marzo 2004, pp.145-8, PMID 15119534.
S. Vandel, G. Bertschy; JM. Jounet; G. Allers, Valpromide increases the plasma concentrations of amitriptyline and its metabolite nortriptyline in depressive patients., in Ther Drug Monit, vol.10, n.4, 1988, pp.386-9, PMID 3144066.
G. Bertschy, S. Vandel; JM. Jounet; G. Allers, [Valpromide-amitriptyline interaction. Increase in the bioavailability of amitriptyline and nortriptyline caused by valpromide]., in Encephale, vol.16, n.1, pp.43-5, PMID 2109680.
pubchem.ncbi.nlm.nih.gov
dipropilacetamide - Compound Summary, su PubChem Compound, USA, National Center for Biotechnology Information, 24 giugno 2005, Identification and Related Records. URL consultato il 21 febbraio 2012.
